Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249779 · ClinicalTrials.gov registry record · NA
Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03249779: Completed NA study, sponsored by Mayo Clinic.
NCT03249779 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03249779, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations and urge to move in patients with restless legs syndrome/Willis Ekbom Disease (RLS/WED).
Interventions
- DEVICE Scrambler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03249779
The ClinicalTrials.gov registry entry for NCT03249779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Scrambler is the first listed.
NCT03249779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03249779 about?
NCT03249779 is a clinical study titled "Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation". To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations and urge to move in patients with restless legs syndrome/Willis Ekbom Disease (RLS/WED).
What is the current status of trial NCT03249779?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-12. Estimated completion is 2018-06.
What interventions are being tested in trial NCT03249779?
The interventions under investigation include: Scrambler (DEVICE).
Who is sponsoring clinical trial NCT03249779?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.